Publications by authors named "Eric Horwitz"

Claim this Profile
P
Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up of NRG Oncology RTOG 9911.
Corey J Langer, Jonathan Harris, Eric M Horwitz, Merrill Kies, Voichita Bar Ad

Int J Radiat Oncol Biol Phys· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARTIA-Cervix: a prospective trial of adaptive radiation therapy for cervical cancer.
Jyoti S Mayadev, Kevin V Albuquerque, Jeremy G Price, Samuel Marcrom, Brian A Hrycushko, Eric M Horwitz

Int J Gynecol Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computed Tomography-Guided Online Adaptive Stereotactic Body Radiation Therapy for Liver Tumors: A Retrospective Study.
Alexander Lukez, Li Zhang, Eric M Horwitz, Thomas J Galloway, Mark A Hallman

Int J Radiat Oncol Biol Phys· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium.
Amar U Kishan, Yilun Sun, Alison C Tree, Emma Hall, David Dearnaley, Eric Horwitz

Lancet Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1).
Daniel M Geynisman, Philip H Abbosh, Eric Ross, Matthew R Zibelman, Pooja Ghatalia, Eric M Horwitz

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trials.
John Nikitas, Parsa Jamshidian, Alison C Tree, Emma Hall, David Dearnaley, Eric Horwitz

Lancet Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostat Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial" [Eur. Eurol. 84(2) (2023) 156-163].
Oliver Sartor, Theodore G Karrison, Howard M Sandler, Leonard G Gomella, Mahul Amin, Eric M Horwitz

Eur Urol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of perioperative and subacute postoperative complications between LDR and HDR monotherapy brachytherapy for prostate cancer.
Peter L Lee, Karen Ruth, Douglas Y Lee, Mark A Hallman, David Y T Chen, Eric M Horwitz

Brachytherapy· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial.
Loren K Mell, Stephanie L Pugh, Christopher U Jones, Tyler J Nelson, Kaveh Zakeri, Eric M Horwitz

Eur Urol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pooled patient-reported outcomes analysis of moderately hypofractionated proton beam therapy and photon-based intensity modulated radiation therapy for low- or intermediate-risk prostate cancer.
Alexander Lukez, Elizabeth Handorf, Nancy P Mendenhall, Randal H Henderson, Bradley J Stish, Eric M Horwitz

Prostate· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202.
Kimberley S Mak, Molly Scannell Bryan, James J Dignam, William U Shipley, Yue Lin, Eric M Horwitz

Eur Urol Focus· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dosimetric analysis of rectal hydrogel spacer use in patients with recurrent prostate cancer undergoing salvage high-dose-rate brachytherapy.
Charles T Lee, Olufela Koleoso, Mengying Deng, Iavor Veltchev, Teh Lin, Eric M Horwitz

Brachytherapy· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of Healium.
Michael A Diefenbach, Allison Marziliano, Erin K Tagai, Halie Pfister, Emmanuel Lapitan, Eric M Horwitz

J Med Internet Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial.
Oliver Sartor, Theodore G Karrison, Howard M Sandler, Leonard G Gomella, Mahul B Amin, Eric M Horwitz

Eur Urol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer.
Himanshu R Lukka, Snehal Deshmukh, Deborah W Bruner, Jean-Paul Bahary, Colleen A F Lawton, Eric M Horwitz

Int J Radiat Oncol Biol Phys· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study.
Mark T Corkum, Mark K Buyyounouski, Albert J Chang, Hans T Chung, Peter Chung, Eric M Horwitz

Radiother Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study.
Noah M Hahn, Michael A O'Donnell, Jason A Efstathiou, Marianna Zahurak, Gary L Rosner, Eric M Horwitz

Eur Urol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Results of a Phase 3 Randomized Prospective Trial of Erectile Tissue-Sparing Intensity-Modulated Radiation Therapy for Men With Clinically Localized Prostate Cancer.
Eddie Zhang, Karen J Ruth, Mark K Buyyounouski, Robert A Price, Robert G Uzzo, Eric M Horwitz

Int J Radiat Oncol Biol Phys· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.
Sagar A Patel, Ting Martin Ma, Jessica K Wong, Bradley J Stish, Robert T Dess, Eric M Horwitz

Int J Radiat Oncol Biol Phys· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Validation of an Alternative Specimen Collection Kit for SARS-CoV-2 Testing at Fox Chase Cancer Center.
Don A Baldwin, Cheyenne R Gigli, Tim Kwok, Sharon Connelly, James L Helstrom, Eric M Horwitz

J Biomol Tech· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions.
James A Eastham, Gregory B Auffenberg, Daniel A Barocas, Roger Chou, Tony Crispino, Eric M Horwitz

J Urol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management.
James A Eastham, Gregory B Auffenberg, Daniel A Barocas, Roger Chou, Tony Crispino, Eric M Horwitz

J Urol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up.
James A Eastham, Gregory B Auffenberg, Daniel A Barocas, Roger Chou, Tony Crispino, Eric M Horwitz

J Urol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415.
Rahul Khairnar, Lyudmila DeMora, Howard M Sandler, W Robert Lee, Ester Villalonga-Olives, Eric M Horwitz

JCO Clin Cancer Inform· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine.
Rebecca M Shulman, David S Weinberg, Eric A Ross, Karen Ruth, Glenn F Rall, Eric M Horwitz

J Natl Compr Canc Netw· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis